Literature DB >> 6712598

Interaction of the radiolabelled high-affinity anti-oestrogen [3H]H1285 with the cytoplasmic oestrogen receptor.

J L Keene, F Sweet, M F Ruh, T S Ruh.   

Abstract

The high-affinity triarylethylene anti-oestrogen H1285 [4-(NN-diethylaminoethoxy)-beta-ethyl-alpha-(p-hydroxyphenyl) -4'-methoxystilbene] was tritiated to high specific radioactivity (35 Ci/mmol). Competition experiments between [3H]H1285 and H1285 or oestradiol demonstrated that both compounds would compete with [3H]H1285 for oestrogen-specific binding sites in rat uterine cytosol. [3H]H1285 had at least 10 times the affinity for the receptor compared with oestradiol at the 50% competition level. [3H]H1285 appeared to have at least twice the association rate for the oestrogen receptor compared with [3H]oestradiol. In addition, the dissociation half-life (t1/2) of specific binding of [3H]H1285 to oestrogen receptors at 0 degrees C was about 220 h compared with a value of 60 h for [3H]oestradiol. Because of the extremely slow dissociation of [3H]H1285 from the oestrogen receptor, we were able to compare the sedimentation profiles of [3H]H1285-receptor complexes with those of [3H]oestradiol-receptor complexes in the presence of 0.4 M-KCl on 5-20% sucrose density gradients. [3H]Oestradiol-receptor complexes had a major peak at 4.4 S with a smaller peak at 5.6 S, whereas with [3H]H1285-receptor complexes the 5.6 S peak was always higher than the 4.4 S peak. There was significant variation between the dissociation behaviour at 20 degrees C of [3H]H1285-receptor complexes and [3H]oestradiol-receptor complexes pre-activated at 25 degrees C for 30 min in the presence and in the absence of 10 mM-sodium molybdate. The dissociation t1/2 of [3H]oestradiol-receptor complexes at 20 degrees C decreased from 1.5 h to 0.5 h when molybdate was present during heat treatment whereas the dissociation t1/2 for [3H]H1285-receptor complexes was 5 h for both conditions. These observations indicate that there are fundamental differences in the initial interaction of H1285 and oestradiol with the oestrogen receptor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712598      PMCID: PMC1153286          DOI: 10.1042/bj2170819

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  12 in total

Review 1.  Estrogen and antiestrogen action in reproductive tissues and tumors.

Authors:  B S Katzenellenbogen; H S Bhakoo; E R Ferguson; N C Lan; T Tatee; T S Tsai; J A Katzenellenbogen
Journal:  Recent Prog Horm Res       Date:  1979

2.  Studies on the mechanism of action of the nonsteroidal antioestrogen tamoxifen (I.C.I. 46,474) in the rat.

Authors:  V C Jordan; C J Dix; L Rowsby; G Prestwich
Journal:  Mol Cell Endocrinol       Date:  1977-04       Impact factor: 4.102

3.  The binding of [3H]oestradiol-receptor complexes to calf uterine chromatin.

Authors:  T S Ruh; P Ross; D M Wood; J L Keene
Journal:  Biochem J       Date:  1981-10-15       Impact factor: 3.857

4.  Inhibition of uterine estrogen receptor transformation by sodium molybdate.

Authors:  G Shyamala; L Leonard
Journal:  J Biol Chem       Date:  1980-07-10       Impact factor: 5.157

5.  Antiestrogen modulation of the salt-resistant nuclear estrogen receptor.

Authors:  T S Ruh; L J Baudendistel
Journal:  Endocrinology       Date:  1978-06       Impact factor: 4.736

6.  Differences between oestrogen receptor activation by oestrogen and antioestrogen.

Authors:  H Rochefort; J L Borgna
Journal:  Nature       Date:  1981-07-16       Impact factor: 49.962

7.  Antifertility activities in the mouse and rat of triarylalkenes and triarylalkanols with basic ether groups.

Authors:  C W Emmens
Journal:  J Reprod Fertil       Date:  1973-07

8.  Different nuclear binding sites for antiestrogen and estrogen receptor complexes.

Authors:  T S Ruh; L J Baudendistel
Journal:  Endocrinology       Date:  1977-02       Impact factor: 4.736

9.  High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite.

Authors:  J L Borgna; H Rochefort
Journal:  Mol Cell Endocrinol       Date:  1980-10       Impact factor: 4.102

10.  Antiestrogenic and antifertility compounds. 4. 1,1,2-Triarylalkan-1-ols and 1,1,2-Triarylalk-1-enes containing basic ether groups.

Authors:  D J Collins; J J Hobbs; C W Emmens
Journal:  J Med Chem       Date:  1971-10       Impact factor: 7.446

View more
  2 in total

1.  Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites.

Authors:  B S Katzenellenbogen; M A Miller; A Mullick; Y Y Sheen
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

2.  Differences in oestrogen receptors in malignant and normal breast tissue as identified by the binding of a new synthetic progestogen.

Authors:  M J Iqbal; A A Colletta; S D Houmayoun-Valyani; M Baum
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.